Pharmaceutical Contract Research Services Market

Chapter Outlines

Chapter 2 is an executive summary of the key insights captured in our research. It offers a high-level view on the likely evolution of the pharmaceutical CROs market in the mid to long term. 

Chapter 3 provides a general introduction to the process of drug discovery and development. The chapter highlights the challenges associated with small molecule drug discovery along with a detailed discussion on the need for outsourcing within the pharmaceutical industry and guidelines for selecting the right service provider.

Chapter 4 provides a comprehensive overview of the global pharmaceutical services market, highlighting the contributions of over 500 CROs. It features a detailed assessment of the market, based on a number of relevant parameters, such as year of establishment, company size, scale of operation (discovery, preclinical and clinical), location of headquarters, types of services offered (target discovery & validation, hit identification, hit-to-lead and lead generation, lead optimization, bioanalytical studies, other preclinical services, clinical trials related services, consulting and regulatory affairs management), hit identification strategy used (high-throughput screening, fragment based screening, virtual screening (structure based virtual screening, ligand based virtual screening and unspecified virtual screening), knowledge based screening, DNA Encoded Library (DEL) based screening and others), type of business model (fee-for-service and full time equivalent) and target therapeutic area.

Chapter 5 provides detailed profiles of some of the key players that are active in the pharmaceutical contract research services market. Each profile presents a brief overview of the company, its financial information (if available), service portfolio and recent developments and an informed future outlook. 

Chapter 6 features a comprehensive company competitiveness analysis, highlighting prominent pharmaceutical contract service providers based in North America, Europe, Asia-Pacific and Rest of the world, that we came across during our research. The analysis compares companies within each geography on the basis of supplier strength (considering a company’s years of experience), and service strength (which takes into account the service offerings, scale of operation, hit identification strategies and subject specific agreements).

Chapter 7 features an elaborate analysis and discussion on the collaborations and partnerships that have been inked amongst players, since 2018. It includes brief descriptions of the various partnership models (including acquisition, clinical trial, platform utilization, product development, research, research and development, service, service alliance and others) that have been adopted by stakeholders in this domain. It also includes analysis based on year of agreement, type of agreement, scale of operation and target therapeutic area. Further, the chapter features a world map representation of all the deals inked in this field, highlighting those that have been established within and across different continents.

Chapter 8 presents a detailed analysis of the various mergers and acquisitions that have taken place in this domain, during the period 2018-2021. It is worth mentioning that the data captured during our research was analyzed based on multiple parameters, such as year, type of acquisition and geographical location of the companies.

Chapter 9 presents an insightful market forecast analysis, highlighting the likely growth of the pharmaceutical CROs market till the year 2031. In order to provide details on the future opportunity, our projections have been segmented on the basis of [A] scale of operation (discovery services, preclinical services and clinical stage services), [B] target therapeutic area (cardiovascular disorder, dermatological disorder, infectious disorder, inflammatory disorder, neurological disorder, oncological disorder,  ophthalmological disorder, respiratory disorder and other disorders) and [C] key geographical region (North America, Europe, Asia-Pacific, Latin America, MENA (Middle East and North Africa) and rest of the world).  

Chapter 10 features a detailed analysis of the total cost of ownership for a pharmaceutical contract research service provider in key geographical regions (US, Europe and Asia-Pacific). It presents estimated direct and indirect expenses taking into consideration close to 100 relevant parameters over a span of 20 years.

Chapter 11 features a case study on the current market landscape of biopharmaceutical contract research service providers, including information on the year of establishment, company size, scale of operation and type of services offered.

Chapter 12 features the transcript of the discussion(s) held with key stakeholder(s) in the industry. 

Chapter 13 is a summary of the entire report. In this chapter, we have provided a list of key takeaways from the report, and expressed our independent opinion related to the research and analysis described in the previous chapters.

Chapter 14 is an appendix that contains tabulated data and numbers for all the figures provided in the report.

Chapter 15 is an appendix that provides the list of companies and organizations mentioned in the report.

Table Of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION 
3.1. Chapter Overview
3.2. Overview of Drug Development
3.3. Drug Discovery Process
3.3.1. Target Identification
3.3.2. Target Discovery and Validation
3.3.3. Hit Generation 
3.3.3.1. High-Throughput Screening
3.3.3.2. Fragment-based Screening
3.3.3.3. Virtual Screening
3.3.3.4. DNA-Encoded Libraries Screening
3.3.4. Hit-to-Lead and Lead Generation
3.3.5. Lead Optimization

3.4. Challenges Associated with Small Molecule Discovery
3.5. Need for Outsourcing Drug Discovery Operations
3.6 Guidelines for Selecting a Contract Research Service Provider
3.7. Concluding Remarks

4. PHARMACEUTICAL CONTRACT RESEARCH SERVICE PROVIDERS: MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Pharmaceutical Contract Research Service Providers: List of Industry Players
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Scale of Operation
4.2.4. Analysis by Location of Headquarters
4.2.5. Analysis by Company Size and Scale of Operation 
4.2.6. Analysis by Types of Services Offered
4.2.7. Analysis by Location of Headquarters and Types of Services Offered 
4.2.8. Analysis by Hit Identification Strategy Used 
4.2.9. Analysis by Type of Business Model
4.2.10. Analysis by Target Therapeutic Area

5. COMPANY PROFILES
5.1. Chapter Overview
5.2. Pharmaceutical Contract Research Service Providers in North America
5.2.1. Albany Molecular Research (AMRI)
5.2.1.1. Company Overview
5.2.1.2. Financial Information
5.2.1.3. Service Portfolio
5.2.1.4. Recent Developments and Future Outlook

5.2.2. BioDuro
5.2.2.1. Company Overview
5.2.2.2. Service Portfolio
5.2.2.3. Recent Developments and Future Outlook

5.2.3. BOC Sciences
5.2.3.1. Company Overview
5.2.3.2. Service Portfolio
5.2.3.3. Recent Developments and Future Outlook

5.2.4. Catalent Pharma
5.2.4.1. Company Overview
5.2.4.2. Financial Information
5.2.4.3. Service Portfolio
5.2.4.4. Recent Developments and Future Outlook

5.2.5. Charles River Laboratories
5.2.5.1. Company Overview
5.2.5.2. Financial Information
5.2.5.3. Service Portfolio
5.2.5.4. Recent Developments and Future Outlook

5.2.6. ChemDiv
5.2.6.1. Company Overview
5.2.6.2. Service Portfolio
5.2.6.3. Recent Developments and Future Outlook

5.2.7. Covance
5.2.7.1. Company Overview
5.2.7.2. Financial Information
5.2.7.3. Service Portfolio
5.2.7.4. Recent Developments and Future Outlook

5.2.8. Medpace
5.2.8.1. Company Overview
5.2.8.2. Financial Information
5.2.8.3. Service Portfolio
5.2.8.4. Recent Developments and Future Outlook

5.2.9. QPS
5.2.9.1. Company Overview
5.2.9.2. Service Portfolio
5.2.9.3. Recent Developments and Future Outlook

5.3. Pharmaceutical Contract Research Service Providers in Europe
5.3.1. Concept Life Sciences
5.3.1.1. Company Overview
5.3.1.2. Service Portfolio
5.3.1.3. Recent Developments and Future Outlook

5.3.2. Evotec
5.3.2.1. Company Overview
5.3.2.2. Financial Information
5.3.2.3. Service Portfolio
5.3.2.4. Recent Developments and Future Outlook

5.4. Pharmaceutical Contract Research Service Providers in Asia-Pacific
5.4.1. ChemPartner
5.4.1.1. Company Overview
5.4.1.2. Financial Information
5.4.1.3. Service Portfolio
5.4.1.4. Recent Developments and Future Outlook

5.4.2. Pharmaron
5.4.2.1. Company Overview
5.4.2.2. Service Portfolio
5.4.2.3. Recent Developments and Future Outlook

5.4.3. Syngene
5.4.3.1. Company Overview
5.4.3.2. Financial Information
5.4.3.3. Service Portfolio
5.4.3.4. Recent Developments and Future Outlook

5.4.4. Torrent Pharma
5.4.4.1. Company Overview
5.4.4.2. Financial Information
5.4.4.3. Service Portfolio
5.4.4.4. Recent Developments and Future Outlook

5.4.5. WuXi AppTec
5.4.5.1. Company Overview
5.4.5.2. Financial Information
5.4.5.3. Service Portfolio
5.4.5.4. Recent Developments and Future Outlook

6. COMPANY COMPETITIVENESS ANALYSIS
6.1. Chapter Overview
6.2. Methodology
6.3. Key Parameters
6.4. Company Competitiveness Analysis: Pharmaceutical Contract Research Service Providers
6.4.1. Pharmaceutical Contract Research Service Providers based in North America
6.4.2. Pharmaceutical Contract Research Service Providers based in Europe
6.4.3. Pharmaceutical Contract Research Service Providers based in Asia- Pacific and Rest of the World

7. PARTNERSHIPS AND COLLABORATIONS
7.1. Chapter Overview
7.2. Partnership Models
7.3. Pharmaceutical Contract Research Service Providers: List of Partnerships and Collaborations
7.3.1. Analysis by Year of Partnership
7.3.2. Analysis by Type of Partnership
7.3.3. Analysis by Scale of Operation
7.3.4. Analysis by Target Therapeutic Area
7.3.5. Analysis by Year of Partnership and Type of Partner
7.3.6. Analysis by Type of Partnership and Type of Partner
7.3.7. Most Active Players: Analysis by Number of Partnerships
7.3.8. Regional Analysis 
7.3.8.1. Intercontinental and Intracontinental Agreements

8. MERGERS AND ACQUISITIONS
8.1. Chapter Overview
8.2. Merger and Acquisition Models
8.3. Pharmaceutical Contract Research Service Providers: Mergers and Acquisitions
8.3.1. Analysis by Year of Acquisition
8.3.2. Analysis by Geography
8.3.3. Intercontinental and Intracontinental Deals
8.4. Analysis by Key Value Drivers
8.4.1. Mergers and Acquisitions: Analysis by Key Value Drivers
8.5. Valuation Analysis: Acquisition Deal Multiples
8.5.1. Prominent Acquirers: Analysis by Number of Acquisitions

9. MARKET FORECAST AND OPPORTUNITY ANALYSIS
9.1. Chapter Overview
9.2. Forecast Methodology and Key Assumptions
9.3. Global Pharmaceutical Contract Research Service Providers Market, 2021-2030
9.4. Global Pharmaceutical Contract Research Service Providers Market, 2021-2030: Distribution by Scale of Operation
9.4.1. Global Pharmaceutical Contract Research Service Providers Market for Discovery Services, 2021-2030
9.4.2. Global Pharmaceutical Contract Research Service Providers Market for Preclinical Services, 2021-2030
9.4.3. Global Pharmaceutical Contract Research Service Providers Market for Clinical Services, 2021-2030

9.5. Global Pharmaceutical Contract Research Service Providers Market, 2021-2030: Distribution by Target Therapeutic Area
9.5.1. Global Pharmaceutical Contract Research Service Providers Market for Oncological Disorders, 2021-2030
9.5.2. Global Pharmaceutical Contract Research Service Providers Market for Infectious Diseases, 2021-2030
9.5.3. Global Pharmaceutical Contract Research Service Providers Market for Neurological Disorders, 2021-2030
9.5.4. Global Pharmaceutical Contract Research Service Providers Market for Inflammatory Disorders, 2021-2030
9.5.5. Global Pharmaceutical Contract Research Service Providers Market for Cardiovascular Disorders, 2021-2030
9.5.6. Global Pharmaceutical Contract Research Service Providers Market for Dermatological Disorders, 2021-2030
9.5.7. Global Pharmaceutical Contract Research Service Providers Market for Ophthalmological Diseases, 2021-2030
9.5.8. Global Pharmaceutical Contract Research Service Providers Market for Respiratory Disorders, 2021-2030
9.5.9. Global Pharmaceutical Contract Research Service Providers Market for Other Disorders, 2021-2030

9.6. Global Pharmaceutical Contract Research Service Providers Market, 2021-2030: Distribution by Region
9.6.1. Pharmaceutical Contract Research Service Providers Market in North America, 2021-2030
9.6.2. Pharmaceutical Contract Research Service Providers Market in Europe, 2021-2030
9.6.3. Pharmaceutical Contract Research Service Providers Market in Asia-Pacific, 2021-2030
9.6.4. Pharmaceutical Contract Research Service Providers Market in Middle East, 2021-2030
9.6.5. Pharmaceutical Contract Research Service Providers Market in Latin America, 2021-2030

10. TOTAL COST OF OWNERSHIP IN PHARMACEUTICAL CONTRACT RESEARCH ORGANIZATION
10.1. Chapter Overview
10.2. Key Assumptions and Methodology
10.3. Output

11. CASE STUDY: BIOPHARMACEUTICAL CONTRACT RESEARCH SERVICES MARKET
11.1. Chapter Overview
11.2. Biopharmaceutical CROs: Overall Market Landscape
11.2.1. Analysis by Year of Establishment, Company Size and Location of Headquarters
11.2.2. Analysis by Scale of Operation

11.3. Preclinical Biopharmaceutical CROs
11.3.1. Analysis by Year of Establishment
11.3.2. Analysis by Company Size
11.3.3. Analysis by Location of Headquarters
11.3.4. Analysis by Type of Biologic
11.3.5. Analysis by Type of Services Offered

11.4. Clinical Biopharmaceutical CROs
11.4.1. Analysis by Year of Establishment
11.4.2. Analysis by Company Size
11.4.3. Analysis by Location of Headquarters
11.4.4. Analysis by Type of Biologics
11.4.5. Analysis by Type of Services Offered

12. EXECUTIVE INSIGHTS
12.1. Chapter Overview
12.2. ChemoGenics Biopharma
12.2.1. Company Snapshot
12.2.2. Interview Transcript: Francis X. Tavares, Founder and Chief Executive Officer

13. CONCLUDING REMARKS

14. APPENDIX 1: TABULATED DATA

List Of Figures

Figure 3.1 Drug Discovery and Development Pipeline
Figure 3.2 Drug Discovery Process
Figure 3.3 Guidelines for Selecting a Contract Research Service Provider
Figure 4.1 Pharmaceutical Contract Research Service Providers: Distribution by Year of Establishment
Figure 4.2 Pharmaceutical Contract Research Service Providers: Distribution by Company Size
Figure 4.3 Pharmaceutical Contract Research Service Providers: Distribution by Scale of Operation
Figure 4.4 Pharmaceutical Contract Research Service Providers: Distribution by Location of Headquarters
Figure 4.5 World Map Representation: Analysis by Geography
Figure 4.6 Pharmaceutical Contract Research Service Providers: Distribution by Company Size and Scale of Operation
Figure 4.7 Pharmaceutical Contract Research Service Providers: Distribution by Types of Services Offered
Figure 4.8 Pharmaceutical Contract Research Service Providers: Distribution by Location of Headquarters and Types of Services Offered
Figure 4.9 Pharmaceutical Contract Research Service Providers: Distribution by Hit Identification Strategy Used
Figure 4.10 Pharmaceutical Contract Research Service Providers: Distribution by Type of Business Model
Figure 4.11 Pharmaceutical Contract Research Service Providers: Distribution by Target Therapeutic Area
Figure 5.1 Catalent Pharma: Annual Revenues, 2016-9M 2021 (USD Billion)
Figure 5.2 Charles River Laboratories: Annual Revenues, 2016-3M 2021 (USD Billion)
Figure 5.3 Covance: Annual Revenues, 2016-3M 2021 (USD Billion)
Figure 5.4 Medpace: Annual Revenues, 2016-3M 2021 (USD Billion)
Figure 5.5 Evotec: Annual Revenues, 2016-3M 2021 (EUR Million)
Figure 5.6 Syngene: Annual Revenues, 2016-2021 (INR Billion)
Figure 5.7 Torrent Pharma: Annual Revenues, 2016-2021 (INR Million)
Figure 5.8 WuXi AppTec: Annual Revenues, 2017-3M 2021 (RMB Billion)
Figure 6.1 Company Competitiveness Analysis: Pharmaceutical Contract Research Service Providers based in North America
Figure 6.2 Company Competitiveness Analysis: Pharmaceutical Contract Research Service Providers based in Europe
Figure 6.3 Company Competitiveness Analysis: Pharmaceutical Contract Research Service Providers based in Asia Pacific and Rest of the World
Figure 7.1 Partnerships and Collaborations: Cumulative Year-wise Trend, 2018-2021
Figure 7.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 7.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 7.4 Partnerships and Collaborations: Distribution by Scale of Operation
Figure 7.5 Partnerships and Collaborations: Distribution by Target Therapeutic Area
Figure 7.6 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partner
Figure 7.7 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Partner
Figure 7.8 Most Active Players: Distribution by Number of Partnerships
Figure 7.9 Partnerships and Collaborations: Regional Distribution
Figure 7.10 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 8.1 Mergers and Acquisitions: Distribution by Year of Merger / Acquisition (2018- 2021)
Figure 8.2 Mergers and Acquisitions: Distribution by Type of Merger / Acquisition
Figure 8.3 Mergers and Acquisitions: Distribution by Year and Type of Merger / Acquisition
Figure 8.4 Mergers and Acquisitions: Continent-wise Distribution
Figure 8.5 Mergers and Acquisitions: Region-wise Distribution
Figure 8.6 Mergers and Acquisitions: Country-wise Distribution
Figure 8.7 Mergers and Acquisitions: Ownership Change Matrix
Figure 8.8 Mergers and Acquisitions: Key Value Drivers
Figure 8.9 Mergers and Acquisitions: Distribution by Year of Acquisition and Key Value Drivers
Figure 8.10 Mergers and Acquisitions: Deal Multiples Based on Revenue
Figure 8.11 Mergers and Acquisitions: Deal Multiples Based on Year of Experience
Figure 9.1 Global Pharmaceutical Contract Research Services Market, 2021-2030 (USD Billion)
Figure 9.2 Global Pharmaceutical Contract Research Services Market, 2021-2030: Distribution by Scale of Operation (USD Billion)
Figure 9.3 Global Pharmaceutical Contract Research Services Market for Discovery Services, 2021-2030 (USD Billion)
Figure 9.4 Global Pharmaceutical Contract Research Services Market for Preclinical Services, 2021-2030 (USD Billion)
Figure 9.5 Global Pharmaceutical Contract Research Services Market for Clinical Stage Services, 2021-2030 (USD Billion)
Figure 9.6 Global Pharmaceutical Contract Research Services Market, 2021-2030: Distribution by Target Therapeutic Area (USD Billion)
Figure 9.7 Global Pharmaceutical Contract Research Services Market for Oncological Disorders, 2021-2030 (USD Billion)
Figure 9.8 Global Pharmaceutical Contract Research Services Market for Infectious Diseases, 2021-2030 (USD Billion)
Figure 9.9 Global Pharmaceutical Contract Research Services Market for Neurological Disorders, 2021-2030 (USD Billion)
Figure 9.10 Global Pharmaceutical Contract Research Services Market for Inflammatory Disorders, 2021-2030 (USD Billion)
Figure 9.11 Global Pharmaceutical Contract Research Services Market for Cardiovascular Disorders, 2021-2030 (USD Billion)
Figure 9.12 Global Pharmaceutical Contract Research Services Market for Dermatological Disorders, 2021-2030 (USD Billion)
Figure 9.13 Global Pharmaceutical Contract Research Services Market for Ophthalmological Diseases, 2021-2030 (USD Billion)
Figure 9.14 Global Pharmaceutical Contract Research Services Market for Respiratory Disorders, 2021-2030 (USD Billion)
Figure 9.15 Global Pharmaceutical Contract Research Services Market for Other Disorders, 2021-2030 (USD Billion)
Figure 9.16 Global Pharmaceutical Contract Research Services Market, 2021-2030: Distribution by Geography (USD Billion)
Figure 9.17 Global Pharmaceutical Contract Research Services Market in North America, 2021-2030 (USD Billion)
Figure 9.18 Global Pharmaceutical Contract Research Services Market in Europe, 2021-2030 (USD Billion)
Figure 9.19 Global Pharmaceutical Contract Research Services Market in Asia-Pacific, 2021-2030 (USD Billion)
Figure 9.20 Global Pharmaceutical Contract Research Services Market in Middle East and North Africa, 2021-2030 (USD Billion)
Figure 9.21 Global Pharmaceutical Contract Research Services Market in Latin America, 2021-2030 (USD Billion)
Figure 10.1 Total Cost of Ownership in Pharmaceutical Contract Research Organization: Output
Figure 11.1 Biopharmaceutical CROs: Distribution by Year of Establishment, Company Size and Location of Headquarters
Figure 11.2 Biopharmaceutical CROs: Distribution by Scale of Operation
Figure 11.3 Biopharmaceutical Preclinical CROs: Distribution by Year of Establishment
Figure 11.4 Biopharmaceutical Preclinical CROs: Distribution by Company Size
Figure 11.5 Biopharmaceutical Preclinical CROs Distribution by Location of Headquarters
Figure 11.6 Biopharmaceutical Preclinical CROs: Distribution by Types of Biologics
Figure 11.7 Biopharmaceutical Preclinical CROs: Distribution by Types of Services Offered
Figure 11.8 Biopharmaceutical Preclinical CROs: Distribution by Number of Services Offered
Figure 11.9 Biopharmaceutical Preclinical CROs: Distribution by Types of Biologics and Types of Services Offered
Figure 11.10 Biopharmaceutical Clinical CROs: Distribution by Year of Establishment
Figure 11.11 Biopharmaceutical Clinical CROs: Distribution by Company Size
Figure 11.12 Biopharmaceutical Clinical CROs: Distribution by Location of Headquarters
Figure 11.13 Biopharmaceutical Clinical CROs: Distribution by Types of Biologics
Figure 11.14 Biopharmaceutical Clinical CROs: Distribution by Types of Services Offered
Figure 11.15 Biopharmaceutical Clinical CROs: Distribution by Number of Services Offered
Figure 11.16 Biopharmaceutical Clinical CROs: Distribution by Types of Biologics and Types of Services Offered
Figure 13.1 Concluding Remarks: Overall Market Landscape
Figure 13.2 Concluding Remarks: Partnerships and Collaborations
Figure 13.3 Concluding Remarks: Mergers and Acquisitions
Figure 13.4 Concluding Remarks: Market Forecast
Figure 13.5 Concluding Remarks: Total Cost of Ownership in Pharmaceutical Contract Research Organization

List Of Tables

Table 4.1 Pharmaceutical Contract Research Service Providers: List of Industry Players
Table 4.2 Pharmaceutical Contract Research Service Providers: Information on Scale of Operation
Table 4.3 Pharmaceutical Contract Research Service Providers: Information on Types of Services Offered
Table 4.4 Pharmaceutical Contract Research Service Providers: Information on Hit Identification Strategy Used
Table 4.5 Pharmaceutical Contract Research Service Providers: Information on Type of Business Model
Table 4.6 Pharmaceutical Contract Research Service Providers: Information on Type of Business Model
Table 4.7 Pharmaceutical Contract Research Service Providers: Information on Target Therapeutic Area
Table 5.1 Pharmaceutical Contract Research Service Providers: List of Profiled Companies
Table 5.2 AMRI: Company Overview
Table 5.3 AMRI: Service Portfolio
Table 5.4 AMRI: Recent Developments and Future Outlook
Table 5.5 BioDuro: Company Overview
Table 5.6 BioDuro: Service Portfolio
Table 5.7 BioDuro: Recent Developments and Future Outlook
Table 5.8 BOC Sciences: Company Overview
Table 5.9 BOC Sciences: Service Portfolio
Table 5.10 BOC Sciences: Recent Developments and Future Outlook
Table 5.11 Catalent Pharma: Company Overview
Table 5.12 Catalent Pharma: Service Portfolio
Table 5.13 Catalent Pharma: Recent Developments and Future Outlook
Table 5.14 Charles River Laboratories: Company Overview
Table 5.15 Charles River Laboratories: Service Portfolio
Table 5.16 Charles River Laboratories: Recent Developments and Future Outlook
Table 5.17 ChemDiv: Company Overview
Table 5.18 ChemDiv: Service Portfolio
Table 5.19 ChemDiv: Recent Developments and Future Outlook
Table 5.20 Covance: Company Overview
Table 5.21 Covance: Service Portfolio
Table 5.22 Covance: Recent Developments and Future Outlook
Table 5.23 Medpace: Company Overview
Table 5.24 Medpace: Service Portfolio
Table 5.25 Medpace: Recent Developments and Future Outlook
Table 5.26 QPS: Company Overview
Table 5.27 QPS: Service Portfolio
Table 5.28 QPS: Recent Developments and Future Outlook
Table 5.29 Concept Life Sciences: Company Overview
Table 5.30 Concept Life Sciences: Service Portfolio
Table 5.31 Concept Life Sciences: Recent Developments and Future Outlook
Table 5.32 Evotec: Company Overview
Table 5.33 Evotec: Service Portfolio
Table 5.34 Evotec: Recent Developments and Future Outlook
Table 5.35 ChemPartner: Company Overview
Table 5.36 ChemPartner: Service Portfolio
Table 5.37 ChemPartner: Recent Developments and Future Outlook
Table 5.38 Pharmaron: Company Overview
Table 5.39 Pharmaron: Service Portfolio
Table 5.40 Pharmaron: Recent Developments and Future Outlook
Table 5.41 Syngene: Company Overview
Table 5.42 Syngene: Service Portfolio
Table 5.43 Syngene: Recent Developments and Future Outlook
Table 5.44 Torrent Pharma: Company Overview
Table 5.45 Torrent Pharma: Service Portfolio
Table 5.46 Torrent Pharma: Recent Developments and Future Outlook
Table 5.47 WuXi AppTec: Company Overview
Table 5.48 WuXi AppTec: Service Portfolio
Table 5.49 WuXi AppTec: Recent Developments and Future Outlook
Table 7.1 Pharmaceutical Contract Research Service Providers: List of Partnerships and Collaborations
Table 8.1 Mergers and Acquisitions: List of Mergers / Acquisitions, 2018-2021
Table 8.2 Mergers and Acquisitions: Information on Key Value Drivers, 2018-2021
Table 8.3 Mergers and Acquisitions: Deal Multiples, 2018-2021
Table 11.2 Biopharmaceutical Preclinical CROs: Information on Types of Services Offered
Table 11.3 Biopharmaceutical Clinical CROs: Information on Types of Services Offered
Table 12.1 ChemoGenics Biopharma: Key Highlights
Table 14.1 Pharmaceutical Contract Research Service Providers: Distribution by Year of Establishment
Table 14.2 Pharmaceutical Contract Research Service Providers: Distribution by Scale of Operation
Table 14.3 Pharmaceutical Contract Research Service Providers: Distribution by Company Size
Table 14.4 Pharmaceutical Contract Research Service Providers: Distribution by Location of Headquarters
Table 14.5 World Map Representation: Analysis by Geography
Table 14.6 Pharmaceutical Contract Research Service Providers: Distribution by Company Size and Scale of Operation
Table 14.7 Pharmaceutical Contract Research Service Providers: Distribution by Types of Services Offered
Table 14.9 Pharmaceutical Contract Research Service Providers: Distribution by Hit Identification Strategy Used
Table 14.10 Pharmaceutical Contract Research Service Providers: Distribution by Type of Business Model
Table 14.11 Pharmaceutical Contract Research Service Providers: Distribution by Target Therapeutic Area
Table 14.12 Catalent Pharma: Annual Revenues, 2016-9M 2021 (USD Billion)
Table 14.13 Charles River Laboratories: Annual Revenues, 2016-3M 2021 (USD Billion)
Table 14.14 Covance: Annual Revenues, 2016-3M 2021 (USD Billion)
Table 14.15 Medpace: Annual Revenues, 2016-3M 2021 (USD Billion)
Table 14.16 Evotec: Annual Revenues, 2016-3M 2021 (EUR Million)
Table 14.17 Syngene: Annual Revenues, 2016-2021 (INR Billion)
Table 14.18 Torrent Pharma: Annual Revenues, 2016-2021 (INR Million)
Table 14.19 WuXi AppTec: Annual Revenues, 2017-3M 2021 (RMB Billion)
Table 14.20 Partnerships and Collaborations: Cumulative Year-wise Trend, 2018-2021
Table 14.21 Partnerships and Collaborations: Distribution by Type of Partnership
Table 14.22 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Table 14.23 Partnerships and Collaborations: Distribution by Scale of Operation
Table 14.24 Partnerships and Collaborations: Distribution by Target Therapeutic Area
Table 14.25 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partner
Table 14.26 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Partner
Table 14.27 Most Active Players: Distribution by Number of Partnerships
Table 14.28 Partnerships and Collaborations: Regional Distribution
Table 14.29 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 14.30 Mergers and Acquisitions: List of Mergers / Acquisitions, 2016 - 2020
Table 14.31 Mergers and Acquisitions: Information on Key Value Drivers, 2016- 2020
Table 14.32 Mergers and Acquisitions: Deal Multiples, 2016- 2020
Table 14.33 Global Pharmaceutical Contract Research Services Market, 2021-2030 (USD Billion)
Table 14.34 Global Pharmaceutical Contract Research Services Market, 2021-2030: Distribution by Scale of Operation (USD Billion)
Table 14.35 Global Pharmaceutical Contract Research Services Market for Discovery Services, 2021-2030 (USD Billion)
Table 14.36 Global Pharmaceutical Contract Research Services Market for Preclinical Services, 2021-2030 (USD Billion)
Table 14.37 Global Pharmaceutical Contract Research Services Market for Clinical Stage Services, 2021-2030 (USD Billion)
Table 14.38 Global Pharmaceutical Contract Research Services Market, 2021-2030: Distribution by Target Therapeutic Area (USD Billion)
Table 14.39 Global Pharmaceutical Contract Research Services Market for Oncological Disorders, 2021-2030 (USD Billion)
Table 14.40 Global Pharmaceutical Contract Research Services Market for Infectious Diseases, 2021-2030 (USD Billion)
Table 14.41 Global Pharmaceutical Contract Research Services Market for Neurological Disorders, 2021-2030 (USD Billion)
Table 14.42 Global Pharmaceutical Contract Research Services Market for Inflammatory Disorders, 2021-2030 (USD Billion)
Table 14.43 Global Pharmaceutical Contract Research Services Market for Cardiovascular Disorders, 2021-2030 (USD Billion)
Table 14.44 Global Pharmaceutical Contract Research Services Market for Dermatological Disorders, 2021-2030 (USD Billion)
Table 14.45 Global Pharmaceutical Contract Research Services Market for Ophthalmological Disorders, 2021-2030 (USD Billion)
Table 14.46 Global Pharmaceutical Contract Research Services Market for Respiratory Disorders, 2021-2030 (USD Billion)
Table 14.47 Global Pharmaceutical Contract Research Services Market for Other Disorders, 2021-2030 (USD Billion)
Table 14.48 Global Pharmaceutical Contract Research Services Market, 2021-2030: Distribution by Geography (USD Billion)
Table 14.49 Global Pharmaceutical Contract Research Services Market in North America, 2021-2030 (USD Billion)
Table 14.50 Global Pharmaceutical Contract Research Services Market in Europe, 2021-2030 (USD Billion)
Table 14.51 Global Pharmaceutical Contract Research Services Market in Asia-Pacific, 2021-2030 (USD Billion)
Table 14.52 Global Pharmaceutical Contract Research Services Market in Middle East and North Africa, 2021-2030 (USD Billion)
Table 14.53 Global Pharmaceutical Contract Research Services Market in Latin America, 2021-2030 (USD Billion)
Table 14.54 Total Cost of Ownership in Pharmaceutical Contract Research Organization: Output
Table 14.55 Biopharmaceutical CROs: Distribution by Year of Establishment, Company Size and Location of Headquarters
Table 14.56 Biopharmaceutical CROs: Distribution by Scale of Operation
Table 14.57 Biopharmaceutical Preclinical CROs: Distribution by Year of Establishment
Table 14.58 Biopharmaceutical Preclinical CROs: Distribution by Company Size
Table 14.59 Biopharmaceutical Preclinical CROs Distribution by Location of Headquarters
Table 14.60 Biopharmaceutical Preclinical CROs: Distribution by Types of Biologics
Table 14.61 Biopharmaceutical Preclinical CROs: Distribution by Types of Services Offered
Table 14.62 Biopharmaceutical Preclinical CROs: Distribution by Number of Services Offered
Table 14.63 Biopharmaceutical Preclinical CROs: Distribution by Types of Biologics and Types of Services Offered
Table 14.64 Biopharmaceutical Clinical CROs: Distribution by Year of Establishment
Table 14.65 Biopharmaceutical Clinical CROs: Distribution by Company Size
Table 14.66 Biopharmaceutical Clinical CROs: Distribution by Location of Headquarters
Table 14.67 Biopharmaceutical Clinical CROs: Distribution by Types of Biologics
Table 14.68 Biopharmaceutical Clinical CROs: Distribution by Types of Services Offered
Table 14.69 Biopharmaceutical Clinical CROs: Distribution by Number of Services Offered
Table 14.70 Biopharmaceutical Clinical CROs: Distribution by Types of Biologics and Types of Services Offered

List Of Companies

1. 2bind
2. 4Clinics
3. A+ Science
4. A10 Clinical Solutions
5. A2 Healthcare
6. Aaranya Biosciences
7. AbClon 
8. Absolute Research Solutions
9. Absorption Systems
10. Accelera
11. Accelero Biostructures
12. Accell Clinical Research
13. Accelsiors
14. Accre Chemicals
15. Accuprec Research Labs
16. Accutest Research Laboratories
17. ACD/Labs
18. ACEA Biosciences
19. ACI Clinical
20. Aclaris Therapeutics
21. ACLIRES International
22. ACM Global Laboratories
23. aCROnordic 
24. ACROVAN
25. Actimus Bio
26. Activa Cro
27. Addex Therapeutics
28. Adesis
29. Advanced Clinical
30. Advanced Drug and Device Services (ADDS)
31. Aepodia
32. African Clinical Research Organization (ACRO) 
33. Agilent
34. AGINKO Research
35. Agno Pharma
36. AiPing Pharmaceutical
37. AIT Bioscience
38. Aix Scientifics
39. Aizant Drug Research Solutions
40. Akcelis
41. Albuquerque Clinical Trials
42. Alcami
43. Alimentiv
44. Alira Health
45. Alliance Pharma
46. Allphase Clinical Research
47. Almac
48. Almirall
49. Alpha Bioresearch
50. Alpha Genesis (AGI)
51. Altasciences
52. Althian- Clinical Research Management Center
53. Altiora
54. Alturas Analytics
55. Amarex Clinical Research
56. AmbioPharma
57. Amedes
58. American Preclinical Services
59. AML Clinical Services
60. AMRI
61. Anabase International
62. Analgesic Solutions
63. Anapharm Bioanalytics
64. Anavo Therapeutics
65. ANI Pharmaceuticals
66. Anova Enterprises
67. AnSys Laboratories
68. ANTAEA
69. Antev
70. APCER Life Sciences
71. APEIRON Biologics
72. A-Pharma
73. Appletree CI Group
74. Applied Healthcare Resource Management (AHRM)
75. APRO
76. ARCHIMEDlife
77. Arcinova
78. Argint International Clinical Research and Development Services (Argint)
79. Aris Pharmaceuticals
80. Array Biostatistics (Acquired by CATO SMS)
81. Asclepia Medchem Solutions
82. Asia Global Research (AGR)
83. Asiatic Clinical Research
84. ASINEX
85. ASSAY Clinical Research
86. Assay.Works
87. Astron Research
88. AstronauTx
89. Atlant Clinical
90. Atuka
91. August Bioservices
92. Auriga Research
93. Aurigene Pharmaceutical Services
94. Aurora Fine Chemicals
95. Aurum Clinical Research (ACR)
96. Avance Clinical (formerly CPR Pharma Services)
97. Averica Discovery 
98. Avistron Chemistry Services
99. Avitacor
100. AVVA Pharmaceuticals
101. AXIS Clinicals
102. Axon Clinical Research
103. Axon Medchem
104. Axxam
105. Azidus
106. BalticCRO
107. Biomedical Advanced Research and Development Authority (BARDA)
108. BASF
109. Baxter
110. Bayer
111. BBK Worldwide
112. BePharBel Manufacturing
113. Bienta (a part of Enamine Biology Services)
114. BioAge Labs
115. Bioanalytical Laboratory Services (BLS)
116. BioAscent
117. BioBlocks
118. Bioclinica
119. BioDuro
120. Biogen
121. Biognos
122. BIOMAPAS CODE OF ETHICS
123. Biomere
124. Bioneeds
125. Bionicsgene
126. BioNTech
127. BioPharma Services
128. BioPredict
129. Biorasi Clinical Research
130. BioReliance
131. bioskin
132. BioSolveIT
133. Biospective
134. BioStat International
135. BioTek Instruments (part of Agilent Technologies)
136. Biotoxtech
137. Biotrial
138. Biotrofix
139. Biovantix
140. BioVectra
141. BlueClinical
142. Blueprint Genetics
143. BOC Sciences
144. Boston MedTech Advisors
145. BPI Service (subsidiary of Federal Association of the Pharmaceutical Industry)
146. BRI Biopharmaceutical Research
147. BTS Research
148. Buffalo Institute for Genomics and Data Analytics (BIG)
149. C&R Research
150. C.RIS Pharma
151. Calmark 
152. Cambrex Zenara (formerly known as Zenara Pharma)
153. Cambridge Regulatory Services
154. Carna Biosciences
155. Cascade Chemistry
156. Casma Therapeutics
157. Catalent Pharma
158. Catalyst Clinical Services
159. CATO SMS
160. CCDRD 
161. CCS Associates (CCSA)
162. CD BioSciences
163. Cedilla Therapeutics
164. Celerion
165. Center for Pharmacology and Analysis (CEPHA)
166. Cerbios-Pharma
167. Certara
168. Certus International
169. Charles River Laboratories
170. CHDI Foundation
171. Checkpoint Therapeutics 
172. ChemAxon
173. ChemBio Discovery Solutions
174. ChemBridge
175. ChemDiv
176. ChemModeling
177. ChemoGenics BioPharma
178. Chemotargets
179. ChemPartner
180. Chongqing Huapont Pharmaceutical
181. CIRION
182. Cliantha Research
183. ClinAudits
184. ClinBAY
185. ClinChoice
186. ClinDatrix
187. Clinfinity
188. Clinical Research Consulting
189. Clinical Service Center (CSC)
190. Clinical Trial Service (CTS)
191. ClinicalConnection
192. Clinilabs
193. Clinipace
194. CliniRx
195. CLINTRIA
196. Clinitude
197. Clinlogix
198. ClinMax
199. Clinres Farmacija
200. ClinServ
201. ClinSmart
202. ClinSoft
203. Clinstat Consulting
204. Clintec
205. CluePoints
206. CMIC Holdings
207. CNS Contract Research
208. CNS Pharmaceuticals
209. Cohortias
210. Colorado Computational
211. Comac Medical
212. ComInnex
213. Commonwealth Biotechnologies
214. Comparative Biosciences
215. Concentrics Research
216. Concept Life Sciences
217. Confluence Discovery Technologies
218. Confo Therapeutics
219. Congenix
220. Conifer Point Consulting
221. Contract Pharmaceuticals
222. Convex CRO
223. CordenPharma
224. CordenPharma
225. CoreRx
226. Corlexia Clinical Services
227. CORONIS Research
228. Covance
229. CreaGen
230. Creative Biostructure
231. Credevo
232. Crelux
233. Cresset
234. Criterium
235. CRM-CRO
236. Crocus Medical
237. Cromos Pharma
238. CROPRIME
239. Crown CRO
240. CTI
241. CW Research & Management
242. CytoAgents
243. Cytovation
244. Dabur Research Foundation (DRF)
245. Dalriada Drug Discovery
246. Dalton Pharma Services
247. Datapharm 
248. DaVinci Biomedical Research Products
249. DaVita Clinical Research
250. Deshpande Laboratories
251. dicentra
252. Dimension Research
253. Direct Biologics
254. DIVERCHIM
255. Divi's Laboratories
256. Dizal Pharmaceutical
257. dMed Biopharmaceutical
258. DMPK4Biotech
259. Domainex
260. Dorian Therapeutics
261. Double Bond Pharmaceutical
262. DP Clinical
263. DPT Laboratories
264. Drik
265. DRK Pharma Solutions
266. DSK InnoSciences
267. DSP Clinical Research
268. DyNAbind
269. DZS Clinical Services
270. EDASA Scientific
271. Edelris
272. EGCP
273. EGeen
274. Emerson
275. Emery Pharma
276. EMINent Services 
277. Emissary International
278. Enamine
279. Epirium Bio
280. Equinox Pharma
281. Ergomed
282. ERT
283. ESTERN Medical CRO 
284. ethica CRO
285. Eurofins Discovery
286. Everest Clinical Research
287. Evonik
288. Evotec
289. ExCellThera
290. Excelya
291. Experimentica
292. Explora BioLabs
293. Farmigea
294. Farzan Clinical Research
295. FGK Clinical Research
296. First Clinical Research
297. Flamma
298. Forma Therapeutics
299. Frontage Laboratories
300. Galapagos 
301. Gavi
302. GB Pharma
303. Gedeon Richter
304. Gencore BioPharma
305. Genentech
306. Genesis Drug Discovery & Development
307. Genetron Holdings
308. Genpro Research
309. George Clinical
310. GI Innovation
311. GI Reviewers
312. Gilead Sciences
313. Global Center for Medical Innovation (GCMI)
314. GMP Bio
315. Gotham Therapeutics
316. GP Pharm
317. Grayline Research Center
318. Green Cross Lab Cell
319. GRK Research Laboratories
320. GVK Biosciences
321. H&J CRO International
322. Hamamatsu Pharma Research (HPR)
323. Harvis Pharm
324. Health Decisions
325. HealthCare Global Enterprises
326. Highlight Therapeutics
327. Hikma Pharmaceuticals
328. Hippocrates Research (HR)
329. HitGen
330. Holburn Biomedical
331. Hoth Therapeutics
332. HungaroTrial
333. Hurley Consulting Associates
334. Hyperion Biotechnology
335. ICON
336. International Drug Development Institute (IDDI)
337. IIT Delhi
338. IKCON PHARMA
339. Immunocure Discovery Solutions
340. Imperial Clinical Research Services
341. Imperial College London
342. ImQuest BioSciences
343. InCROM
344. Indivirtus
345. Info Kinetics
346. InformedDNA
347. IniXium
348. Innovative Informatica Technologies
349. Inotiv
350. Inoviem
351. Inspire
352. Integral Biosciences
353. Integrium
354. InteRNA Technologies
355. International Clinical Trials Association
356. International HealthCare (IHC) 
357. Intonation Research Laboratories
358. Intrials Clinical Research
359. Invivoscribe 
360. IonsGate Preclincal Services 
361. IPS Therapeutique (IPST)
362. IQVIA
363. IRBM
364. Iris Pharma
365. IRW
366. Isochem
367. JANIX
368. Janssen Biotech
369. Jehangir Clinical Development Centre (JCDC)
370. JOANNEUM RESEARCH
371. JRF Global
372. JSS Medical Research
373. Jubilant Biosys
374. Julius Clinical
375. Kalexsyn
376. KCAS Bioanalytical and Biomarker Services
377. KCR
378. Key Organics
379. Klinar
380. KMR Group
381. KP Pharmaceutical Technology
382. KPS Clinical Services
383. Kriger Research International
384. Kymera
385. Lambda Therapeutics Research 
386. Lancaster University
387. Laurus Synthesis
388. LAVA Therapeutics
389. LAXAI Life Sciences (a subsidiary of Laxai Pharma)
390. LegoChem Biosciences (LCB)
391. Leon Research
392. LG Chem
393. Liatris Biosciences
394. Life Chemicals
395. Linical
396. LINK Medical
397. Lipigon
398. Liverpool ChiroChem
399. Lonza
400. Lotus Clinical Research
401. Lotus Pharmaceuticals
402. LSK Global Pharma Services
403. Lubrizol Life Science (LLS Health)
404. Lucid Diagnostics
405. MakroCare
406. Marksman Healthcare
407. Mascot Industries
408. MB Quest
409. Medelis
410. Medfiles
411. Medi Service
412. Medical Data Analytics (MDA)
413. Medicilon
414. Medicines Evaluation Unit (MEU) 
415. Medidata Solutions
416. Mediolanum Cardio Research (MCR)
417. Mediprobe Research
418. Medis Research Group
419. Medpace
420. MedPharm
421. MedReleaf
422. MedTrials
423. MENADIONA
424. MENE Health Group (MHG)
425. Merck & Co.
426. Meruvax Pharma
427. Metrics Champion Consortium (MCC)
428. Metrics Contract Services
429. Metrics Research
430. Micar Innovation
431. Micro Therapeutic Research Labs (MTRL)
432. MicroConstants
433. Micro-Sphere
434. Mitsubishi Tanabe Pharma
435. MLM Medical Labs
436. MMS Holdings
437. Molcan
438. Molecular Cornerstones
439. Molecular Forecaster
440. Molecule CRO
441. Molsoft
442. Moncoa Medical Research
443. Monipol
444. Monitioring Force
445. MonitorCRO
446. Morley Research Consortium
447. Morphic
448. MRI Global
449. MSN Laboratories
450. MTZ Clinical Research
451. My Green Lab
452. Nagy Research
453. Nanjing Pharmatechs
454. Nanosyn
455. Nanyang Technological University (NTU)
456. National Cancer Institute
457. NCGS
458. Neurofit
459. Neurosolutions
460. New England Discovery Partners (NEDP)
461. Next Pharma
462. Nextar Chempharma Solutions
463. NexusPharma
464. NIAID
465. Nitza Bioventure
466. NMX Research and Solutions
467. Noble Life Sciences
468. NorthEast BioLab
469. NorthWise Services
470. Norwich Clinical Research Associates
471. Nostrum Biodiscovery
472. NovaData Solutions
473. NovAlix
474. NovaMechanics
475. Novotech
476. NTZ Lab
477. NuChem Therapeutics
478. Nutrasource
479. Nuvisan Pharma
480. OCT Clinical
481. OMass Therapeutics
482. Oncodesign
483. Oncology Ventures
484. ONCOtherapeutics
485. Onq Research
486. OpenEye Scientific
487. Open Orphan
488. Operatrix Consulting
489. OPN Healthcare
490. Ora Clinical
491. Orbis Clinical
492. Organo Chem
493. Oroxcell
494. Orphan Reach
495. Osong
496. OTAVA Chemicals
497. P3 Research
498. Pacific BioLabs
499. Pacific Bridge Medical
500. Palm Beach CRO
501. Palobiofarma
502. Paraxel
503. Paraza Pharma
504. Patheon by Thermo Fischer Scientific
505. Peachtree BioResearch Solutions
506. PELVIPHARM
507. ProXyChem
508. Pfizer CentreOne®
509. Pharma Inventor
510. Pharma Medica Research
511. Pharmacelera
512. Pharmaceuticals Product Development
513. Pharmaffiliates
514. Pharmahungary
515. PharmAI
516. Pharmalys
517. PharmaResources
518. Pharmaron
519. PharmaSeek (acquired by WCG)
520. Pharmatest Services
521. Pharm-Olam
522. PharmStats
523. PharSafer®
524. PHASTAR
525. PHDS Healthcare Research
526. Phoneix Clinical Research
527. Physiogenex
528. Pierrel SpA
529. pilot Mainz 
530. Pion
531. Piramal Pharma Solutions
532. Pivotal
533. POPSI CUBE
534. Porton Fine Chemicals
535. PPC Group
536. PRA Health Sciences
537. Premier Research
538. Prestwick Chemical
539. Princeton BioMolecular Research
540. Procaps
541. ProDERM
542. Profacgen
543. Profil
544. Proinnovera
545. Promedica International
546. PROMETRIKA
547. ProRelix Research
548. Prosarix 
549. Proswell Medical
550. Proteros Fragments
551. ProtoQSAR
552. Provid Pharmaceuticals
553. Providence Clinical Research
554. Proxima
555. Proximagen
556. ProXyChem
557. ProZyme
558. Prudentia Group
559. PSI
560. Pyramid Laboratories
561. Pyxis Discovery
562. QPS
563. Q-Trials
564. Quality Assistance
565. Quality Chemical Laboratories
566. Quanticate
567. Quartesian
568. Quay Pharmaceuticals
569. Quotient Sciences
570. Raptim Research
571. RASA Lifescience Informatics
572. Raybow Pharmaceuticals
573. Reaction Biology
574. Reaxense
575. Recipharm
576. Red Glead Discovery
577. Redox Scientific
578. Redoxis
579. Reliance Life Sciences
580. Research Assist
581. Resolution Bioscience
582. Resolution Latin America
583. Rho
584. Richmond Pharmacology 
585. Rottendorf Pharma
586. RTI Health Solutions
587. RTI International
588. Sacura
589. Sai Life Sciences
590. Sambi Pharma
591. Sandexis Molecular Design
592. Sanjeevani Bio
593. Sanofi
594. Sarah Cannon Development Innovations
595. SARomics Biostructures
596. Scandinavian CRO
597. Schiff & Company
598. SchinoPharm
599. Scian services
600. Scientific Bio-minds
601. Scimega
602. SchinoPharm
603. Scope International
604. Sekisui Xenotech
605. Selvita
606. SGS Life Sciences
607. SGS Life Sciences
608. Shamrock Structures
609. Siegfried
610. SilcsBio
611. SILLAR CLINICAL 
612. Simbec-Orion
613. Simulations Plus
614. Sinclair Research
615. Sipra Labs
616. SiREEN
617. Sitryx Therapeutics
618. SLG
619. SLR Biosciences
620. Smerud Medical Research Group
621. Smerud Medical Research International
622. SMO India
623. SNBL Japan
624. SoBran Bioscience
625. SOCAR Research
626. SofPromed
627. Solvias
628. SomaLogic
629. Sovereign Pharmaceuticals
630. Spaulding Clinical
631. Spectrum Clinical Research
632. Sphaera Pharma
633. SpiroChem
634. SPRI Ukraine
635. Squarepoint-Pointcare
636. Staidson
637. Standard Medical Products
638. Statistics Collaborative
639. STATKING Clinical Services
640. Stiris Research
641. Strain Chem
642. Strand Life Sciences
643. Strategic Regulatory Consulting
644. Structure Based Design
645. Sugen Life Sciences
646. Sun Pharma Advanced Research Company
647. Sundia
648. Sundia MediTech
649. SuperLab
650. Swiss Pharma
651. Sygnature Discovery
652. Symbio Research
653. Symeres
654. Symphony Pharma Life Science
655. Synapse
656. Synchron 
657. Syneos Health
658. Synergy Research Group
659. Syngene
660. SynphaTec Japon
661. SYNSIGHT
662. Synteract
663. SYNthesis med chem
664. Syreon Clinical Research
665. Sysdata Consulting
666. T3D Therapeutics
667. Takeda Pharmaceutical
668. Target Health
669. Taros Chemicals
670. TCA Clinical Research
671. TCG Lifesciences
672. Tech Observer
673. TFS HealthScience
674. The Alliance for Clinical Trials in Oncology
675. The Avoca Group
676. The Kitasato Institute
677. The Micron Group
678. The Siesta Group
679. The SIRO Clinpharm
680. Theradex Oncology
681. TheraIndx Lifesciences
682. Therapeutics
683. Tigermed
684. TimTec
685. Titan Pharma
686. TKL Research
687. TMG Research
688. Tolmar
689. Tonus-Les
690. Torrent Pharm
691. Toxikon 
692. TransPharm Preclinical Solutions
693. Trennic Data Services
694. Trifecta Clinical
695. Tubilux Pharma (acquired by C.O.C Farmaceutici)
696. ULTRA Scientific
697. Ultratech India
698. Unichem Laboratories
699. Unimark Remedies
700. Unison
701. University of Edinburgh
702. University of Manchester
703. University of Sheffield 
704. UPM Pharmaceuticals
705. UPPTHERA
706. US Pharma Lab
707. USV
708. Vagdevi InnoScience
709. Veeda CRO
710. Velesco Pharmaceutical Services
711. Velos
712. Vergo Pharma Research
713. Veristat
714. Vernalis
715. Verum Clinical Research
716. Vimta Labs
717. Vipergen
718. Vipragen Biosciences
719. Viva Biotech
720. Vlife Sciences
721. Vyome Therapeutics
722. Waife & Associates
723. WellSpring Consumer Healthcare
724. Westat 
725. Wilmington PharmaTech
726. Windlas
727. Windlas Healthcare
728. Winicker Norimed
729. WCG IRB 
730. Wisdom Pharmaceuticals
731. Worldwide Clinical Trials
732. WuXi AppTec
733. XoNovo
734. Xpose Therapeutics
735. Xtal BioStructures
736. Yaadvi Scientific Solutions
737. Yale University
738. Yao Pharma
739. Young In Scientific
740. Yung Zip Chemical
741. Zaggo
742. Zambon
743. ZEINCRO
744. Zenith Healthcare
745. Zenobia Fragments
746. ZenRise
747. Apeloa Pharma
748. Zhejiang Langhua Pharmaceutical
749. ZM Company
750. ZoBio
751. Zydus BSV Pharma

Source 1: www.ncbi.nlm.nih.gov/pmc/articles/PMC4513659/#:~:text=Virtually%20all%20traditional%20drugs%2C%20as,the%20nanomolar%20range%20or%20better
Source 2: www.synteract.com/Services/Contract-Research-Organization